D28C - Mitigating Risk for Inpatient Hypoglycemia utilizing Continuous Glucose Monitoring

The need for a strategy to mitigate inpatient hypoglycemia in an urban tertiary care hospital was identified when hypoglycemia rates < 70mg/dL were found to be 16-18% in 2023. According to CMS, non-adjunctive CGM can independently inform glycemic treatment decisions. Existing inpatient CGM research showing improvement in glycemic outcomes has primarily targeted critical care settings, with few reports of CGM use in medical-surgical units. To address this gap, CGM was introduced on medical-surgical units with a proactive strategy to implement a nurse-driven hospital hypoglycemia protocol when CGM identified a blood glucose level less than 85mg/dL with a downward trend. This session gives an overview of the CMS Policy on Severe Hypoglycemia Harms and discusses the impact of CGM implementation on hypoglycemia rates among adults with T2D on medical-surgical units. Authors: Lyn Hopkinson, DNP, ACNP BC, FNP BC, BC ADM, MedStar Washington Hospital Center; Meeta Sharma, MD, Endocrinologist, Regional and Section Director of Endocrinology, MedStar Washington Hospital Center; Michelle Magee, MD, Professor of Medicine Georgetown University School of Medicine, Emeritus Director MedStar Health Diabetes Institute; Carine Nassar, MS, RD, LDN, CDCES, Program Director, MedStar Diabetes Institute, Diabetes Patient and Digital Engagement Director at MedStar Health; Jennifer Johnson Edwards, DNP, RN, WHNP, CNE, LANP-F, Adjunct Online Faculty Grand Canyon University College of Nursing, Grand Canyon University. Funding source: None